Kory Wentworth
About Kory Wentworth
Kory Wentworth serves as the Chief Financial Officer and Treasurer at Entrada Therapeutics, bringing over 15 years of experience in the biotechnology sector. He has held senior finance roles at companies such as Alexion Pharmaceuticals and bluebird bio, and is a Certified Public Accountant with a strong background in public accounting.
Work at Entrada Therapeutics
Kory Wentworth serves as the Chief Financial Officer and Treasurer at Entrada Therapeutics since 2020. In this role, he oversees the financial operations and strategic financial planning of the organization. His responsibilities include managing financial risks, financial reporting, and ensuring compliance with regulatory requirements. Wentworth's leadership is instrumental in guiding the company's financial strategy and supporting its growth objectives in the biotechnology sector.
Previous Experience in Biotechnology
Before joining Entrada Therapeutics, Kory Wentworth held significant positions in the biotechnology industry. He served as Vice President of Finance and Treasurer at bluebird bio from 2017 to 2020, where he was responsible for financial management and strategy. Prior to that, he worked at Alexion Pharmaceuticals for nine years, holding the role of Executive Director and Corporate Controller. His extensive experience in these roles has equipped him with a deep understanding of the financial dynamics within high-growth biotechnology environments.
Background in Public Accounting
Kory Wentworth has a strong foundation in public accounting, having worked at several prestigious firms. He began his career at Arthur Andersen as an Associate in Assurance and Advisory Business Services. He then moved to KPMG as an Associate in the Government Assurance Practice for a brief period. Following this, he spent six years at PricewaterhouseCoopers as an Audit Manager. This background has provided him with a robust understanding of internal controls and accountability, which he applies in his current role.
Education and Credentials
Kory Wentworth earned a Bachelor of Science degree in Accounting from Susquehanna University, where he studied from 1997 to 2001. He is also a Certified Public Accountant, which underscores his expertise in financial management and compliance. His educational background and professional certifications contribute to his effectiveness in leading finance teams and implementing financial systems in the biotechnology sector.
Achievements in Financial Leadership
Throughout his career, Kory Wentworth has been recognized for delivering high-quality results and insightful analysis through global finance teams. He is known for implementing systems and fostering a culture of continuous improvement within finance teams. His leadership in supporting global product launches and operational scale in the biotechnology sector highlights his capability in managing complex financial operations and driving organizational success.